CIK 0001829635 · <br>Emerging growth company
Transcode Therapeutics, Inc.
Sign in to watch- Ticker
- RNAZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811065054
- Phone
- 857-301-6857
- Business address
- 6 LIBERTY SQUARE, #2382, BOSTON, MA, 02109
- DEF 14A Proxy Proxy Statement
- 8-K Event Director nominations
- 10-Q Report Quarterly Report
- 8-K Event Delisting notice
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Regulation FD disclosure
- 8-K Event Shareholder vote results · Regulation FD disclosure
- 10-K/A Report 10-K/A
- DEFA14A Proxy Proxy Materials
- 8-K Event Shareholder vote results · Other events
- DEFA14A Proxy Proxy Materials
- 10-K Report Annual Report
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- NT 10-K Other NT 10-K
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- SCHEDULE 13D Stake Beneficial Ownership Report
- 8-K Event Shareholder vote results · Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- DEFA14A Proxy Proxy Materials
Page 5 of 17 · 324 filings